Category:
Preclinical Research Services
CAS NO:
178912-62-4
Standard:
USP, EP,
The Levofloxacin 9-Piperazinyl Isomer is a critical stereoisomeric impurity in the synthesis of levofloxacin. It arises during the asymmetric synthesis or resolution processes where chirality at the C9 position of the piperazine ring is not fully controlled. Its presence must be strictly monitored to ensure pharmaceutical purity.
Store in a cool, dry place under inert atmosphere. Handle with appropriate PPE to avoid inhalation or skin contact. Not intended for clinical use as a therapeutic agent due to potential reduced efficacy or safety concerns compared to the pure enantiomer.